Siemens Healthineers, Tarrytown, NY, has appointed Deepak Nath, PhD, as president of laboratory diagnostics. Nath succeeds Franz Walt, who served as president from 2014 through 2017, and led the business unit during its launch of the Atellica solution.
Nath will continue the unit’s endeavor to transform care delivery in the laboratory by growing the business, leveraging his extensive operational experience in healthcare. He will be based in Tarrytown, NY.
“Siemens Healthineers seeks to benefit from market opportunities in the diagnostics market through the introduction of Atellica solution,” says Michael Reitermann, chief operating officer at Siemens Healthineers. “Deepak Nath’s exceptional leadership experience and deep industry knowledge will greatly benefit us as we look to expand the early success of Atellica solution and drive wide adoption in the diagnostics market.”
Nath brings 20 years of wide-ranging leadership experience in healthcare to Siemens Healthineers, including change management, commercial management, general management, research and development, and strategy. For the past 3 years, Nath served as president of Abbott’s vascular division and as an executive officer of the company. His 10-year career there also comprised a variety of global leadership roles, including president of the molecular diagnostics division, divisional vice president, general manager of Ibis Biosciences, and several commercial leadership positions across mature and emerging markets.
Earlier in his career he held positions at Amgen, where he lead process improvement initiatives; at McKinsey, serving a range of clients in the medical device and pharma industries; and at the Lawrence Livermore National Laboratory, where he was a scientist in the computational physics group.
Nath has BS and MS degrees in mechanical engineering and a PhD in theoretical mechanics, all from the University of California, Berkeley.